Position in EOLS
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$103,037
-$50,892 QoQ
Shares Held
25,070
0.0% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BENDER ROBERT & ASSOCIATES holds $328,756 across 2 Drug Manufacturers - Specialty & Generic names. EOLS ranks #2 (31.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
|
23,710 | $225,719 | |
| 2 | EOLS |
Evolus, Inc.
This page
|
25,070 | $103,037 |
All Filings in EOLS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $103,037 | 25,070 | Shares | Sole | 2026-04-23 | |
| 2025-09-30 | $153,929 | 25,070 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $230,894 | 25,070 | Shares | Sole | 2025-07-24 | |
| 2024-12-31 | $276,772 | 25,070 | Shares | Sole | 2025-02-07 | |
| 2023-12-31 | $263,987 | 25,070 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $229,139 | 25,070 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $182,258 | 25,070 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $212,092 | 25,070 | Shares | Sole | 2023-04-21 | |
| 2022-09-30 | $201,813 | 25,070 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $290,812 | 25,070 | Shares | Sole | 2022-07-19 | |
| 2021-03-31 | $324,750 | 25,000 | Shares | Sole | 2021-04-28 | |
| No filing history on record for this holder in this stock. | ||||||